37 related articles for article (PubMed ID: 11266032)
1. Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India.
Deshmukh US; Joglekar CV; Lubree HG; Ramdas LV; Bhat DS; Naik SS; Hardikar PS; Raut DA; Konde TB; Wills AK; Jackson AA; Refsum H; Nanivadekar AS; Fall CH; Yajnik CS
Eur J Clin Nutr; 2010 May; 64(5):495-502. PubMed ID: 20216560
[TBL] [Abstract][Full Text] [Related]
2. Vitamin B12 status and hyperhomocysteinemia in patients with Rheumatoid arthritis treated with methotrexate and folic acid.
Patel AV; Morgan SL; Green R; Danila MI; Merriman TR; Wanzeck K; Ahmed H; Gaffo AL
Am J Med Sci; 2024 Jul; 368(1):33-39. PubMed ID: 38561045
[TBL] [Abstract][Full Text] [Related]
3. Intranasal vitamin B
Tillemans MPH; Giezen TJ; Egberts TCG; Hooijberg JH; Kalisvaart KJ
Br J Clin Pharmacol; 2024 May; ():. PubMed ID: 38747399
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine and methylmalonic acid in Phenylketonuria patients.
Hoss GRW; Sperb-Ludwig F; Tonon T; Poloni S; Behringer S; Blom HJ; Maillot F; Schwartz IVD
Genet Mol Biol; 2024; 46(3 Suppl 1):e20230103. PubMed ID: 38591937
[TBL] [Abstract][Full Text] [Related]
5. Serum Vitamin B12 Deficiency in Chronic Hemodialysis Patients.
Mushtaq M; Usmani MR; Hameed N; Anwar A; Hashmi AA
Cureus; 2024 Apr; 16(4):e58751. PubMed ID: 38779272
[TBL] [Abstract][Full Text] [Related]
6. Influence of dialysis techniques and alternate vitamin supplementation on homocysteine levels in patients with known MTHFR genotypes.
Dessì M; Di Giovamberardino G; Pieri M; Noce A; Zenobi R; Di Daniele N; Pastore A
Clin Exp Nephrol; 2015 Feb; 19(1):140-5. PubMed ID: 24652221
[TBL] [Abstract][Full Text] [Related]
7. Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.
Urquhart BL; Freeman DJ; Cutler MJ; Mainra R; Spence JD; House AA
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1041-7. PubMed ID: 18337551
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
9. Therapy of hyperhomocysteinemia in end-stage renal disease patients.
Hagen W; Födinger M; Hörl WH; Sunder-Plass-Mann G
Minerva Urol Nefrol; 2001 Sep; 53(3):159-70. PubMed ID: 11723441
[TBL] [Abstract][Full Text] [Related]
10. Parenteral vitamin B12 reduces hyperhomocysteinemia in end-stage renal disease.
Kaplan LN; Mamer OA; Hoffer LJ
Clin Invest Med; 2001 Feb; 24(1):5-11. PubMed ID: 11266032
[TBL] [Abstract][Full Text] [Related]
11. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
12. Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease.
Hoffer LJ; Elian KM
Clin Invest Med; 2004 Feb; 27(1):10-3. PubMed ID: 15061579
[TBL] [Abstract][Full Text] [Related]
13. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
[TBL] [Abstract][Full Text] [Related]
14. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
